Sticker shock and the price of new therapies for hepatitis C: is it worth it?
Center for Liver Disease, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medicine, Chicago, IL.
Nancy S
NS
Reau
Donald M
DM
Jensen
D000998:Antiviral Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D017048:Health Care Costs; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D012189:Retrospective Studies; D016896:Treatment Outcome
D000998:Antiviral Agents